Aerpio Therapeutics, Inc.
Biotechnology company · Cincinnati, Ohio, United States
Aerpio Therapeutics, Inc. is a biotechnology company headquartered in Cincinnati, Ohio, United States. Its earliest recorded incorporation is in 2011. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $432,281 in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $3.5 million sold in a notice filed in 2016.
Aerpio Therapeutics at a glance
What does Aerpio Therapeutics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $432,281 in total (2015 to 2019). NIH funding came from the National Eye Institute.
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $3.5 million sold (2016).
Frequently asked questions about Aerpio Therapeutics
Where is Aerpio Therapeutics headquartered?
Aerpio Therapeutics, Inc. is headquartered in Cincinnati, Ohio, United States.
What does Aerpio Therapeutics do?
Aerpio Therapeutics, Inc. is a biotechnology company.
When was Aerpio Therapeutics founded?
The earliest incorporation on record for Aerpio Therapeutics, Inc. is in 2011, according to public company registers.
Similar companies
- Sus Clinicals, Inc.Cincinnati, Ohio, United States
- P2D, IncCincinnati, Ohio, United States
- Megadyne Medical Products, Inc.Cincinnati, Ohio, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences